story of the week
Guselkumab Induction Therapy Has Long-Lasting Efficacy in Patients With Mild Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial
J Am Acad Dermatol 2023 Oct 05;[EPub Ahead of Print], J Rousel, ME Bergmans, LWJ van der Meulen, L Pagan, DT de Bruin, ML de Kam, NB Klarenbeek, JA Bouwstra, MMB Seyger, JMPA van den Reek, T Niemeyer-van der Kolk, R Rissmann, MBA van DoornFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.